Colorectal cancer

C3_COLORECTAL

colorectal cancer: A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_COLON C3_RECTOSIGMOID_JUNCTION C3_RECTUM	9870
6. Filter based on genotype QC (FinnGen only)	9870

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF4

NAME	C3_COLORECTAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_COLON\|C3_RECTOSIGMOID_JUNCTION\|C3_RECTUM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Colorectal cancer based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9870	4167	5703
Unadjusted period prevalence (%)	2.05	1.42	2.51
Median age at first event (years)	68.43	66.84	69.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9130: Matched controls
91307

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

13.7

323.0

654

510

JFB30

NOMESCO Finland

Right hemicolectomy

66.3

323.0

1221

212

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

352.1

323.0

440

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

11.7

323.0

2995

3655

130

Kela drug reimbursment

Malignant tumour

21.3

323.0

4447

3905

UJF32

NOMESCO Finland

Coloscopy

9.9

323.0

6142

15709

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

16384.0

323.0

1427

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

9.1

323.0

903

1083

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

7.7

323.0

808

1130

JG1CG

NOMESCO Finland

Extensive MRI of rectum

110.6

323.0

482

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

16.3

323.0

925

628

A03FA01

ATC

metoclopramide; systemic, rectal

6.4

323.0

4286

11032

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

323.0

768

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

19.3

323.0

1108

649

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

862.3

323.0

333

H02AB02

ATC

dexamethasone; systemic

6.1

323.0

2354

4915

L01BC06

ATC

capecitabine; oral

86.9

323.0

3435

630

TJF80

NOMESCO Finland

Ostomy education

30.5

323.0

566

197

WF001

NOMESCO Finland

Preoperative radiotherapy

115.9

323.0

842

JG1BG

NOMESCO Finland

MRI of rectum

136.3

323.0

611

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

11.1

323.0

1301

1349

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

94.0

323.0

1114

135

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

11.3

323.0

1497

1559

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

2770.0

323.0

543

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

78.6

323.0

719

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

200.2

323.0

1763

109

Z93.3

ICD-10 Finland

Colostomy status

59.4

323.0

553

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

323.0

3711

15516

ZXE20

NOMESCO Finland

More than three and less than five hours

3.3

323.0

2155

7787

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.0

323.0

1335

1917

JN4AD

NOMESCO Finland

Body CT examination

5.8

323.0

1850

3815

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

434.6

323.0

908

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

24.2

323.0

811

367

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

251.9

323.0

363

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

172.2

323.0

773

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

2339.5

323.0

683

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

423

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2962.1

323.0

2890

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

8.3

323.0

1815

2646

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

251.2

323.0

1220

A04AA02

ATC

granisetron; systemic, transdermal

11.9

323.0

2110

2252

B01AB05

ATC

enoxaparin; parenteral

4.1

323.0

4832

19599

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.7

323.0

953

1569

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

293.8

323.0

392

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

16.3

323.0

871

586

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

7.7

323.0

936

1329

WZC30

NOMESCO Finland

Teaching

4.2

323.0

2289

6738

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

150.2

323.0

484

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.7

323.0

3716

18596

C20

ICD-10 Finland

Malignant neoplasm of rectum

1504.3

323.0

819

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

312.3

323.0

663

JN4BD

NOMESCO Finland

Extensive body CT

7.7

323.0

3161

5847

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

547.4

323.0

1670

WX302

NOMESCO Finland

Thoracal epidural anesthesy

16.4

323.0

2277

1807

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

216.6

323.0

607

D75

ICPC

Malignant neoplasm colon/rectum

145.9

323.0

676

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

33.8

323.0

527

165

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

206.6

323.0

741

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

857.3

323.0

488

JFF23

NOMESCO Finland

Transversostomy

63.3

323.0

851

148

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

178.8

323.0

507

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

443.5

323.0

1032

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

3507.4

323.0

348

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

389.0

323.0

3160

124

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

306.1

323.0

598

TPH07

NOMESCO Finland

Cathetrisation of artery

4.2

323.0

1956

5546

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

488.9

323.0

377

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.4

323.0

888

1308

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

353.4

323.0

409

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

365.3

318.8

320

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.0

311.0

1084

2377

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.5

307.7

1654

5417

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

250.0

306.8

314

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

768.3

303.9

298

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

191.8

302.7

315

B01AB10

ATC

tinzaparin; parenteral

4.3

296.8

1231

3214

JFB46

NOMESCO Finland

Resection of sigmoid colon

15.8

289.6

487

324

JN4CD

NOMESCO Finland

Very extensive body CT

5.5

288.9

922

1822

UJG02

NOMESCO Finland

Proctoscopy

9.4

287.6

623

705

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

362.0

281.7

283

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

12.8

280.8

517

425

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

17.0

280.6

458

282

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

348.6

271.3

273

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

96.6

270.0

299

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.3

265.1

675

988

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

339.2

264.0

266

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

1315.5

263.6

256

JFB43

NOMESCO Finland

Left hemicolectomy

28.8

259.8

358

129

JFF10

NOMESCO Finland

Loop enterostomy

40.3

259.3

330

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

47.5

257.6

317

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

72.1

255.9

294

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

327.0

249.4

252

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

5.2

245.7

816

1677

WX600

NOMESCO Finland

Single shot through catheter

15.8

242.2

407

269

WX402

NOMESCO Finland

General anaesthesia

2.8

241.2

1819

7422

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

96.3

236.6

262

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

344.5

235.3

237

Z51.5

ICD-10 Finland

Palliative care

3.7

234.8

1126

3306

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

8.5

228.8

525

651

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

566.7

224.4

222

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

46.6

223.5

276

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

15.1

223.2

382

264

L01BC59

ATC

trifluridine, combinations; systemic

1109.9

222.7

217

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.3

216.7

711

1435

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

1068.0

214.3

209

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

1052.3

211.2

206

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

220.1

208.4

215

N02AA05

ATC

oxycodone; systemic

2.4

200.4

2001

9450

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

102.5

200.0

220

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

337.7

198.4

200

JAH00

NOMESCO Finland

Laparotomy

6.0

197.2

577

1012

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

193.4

940

2768

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

6.4

190.4

527

859

ZX120

NOMESCO Finland

Intravenous

3.0

189.7

1267

4714

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

246.3

188.3

193

369

Kela drug reimbursment

Regorafenib

166.0

185.4

195

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

183.9

176

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

239.8

183.2

188

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

459.2

181.7

181

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

117.2

179.8

195

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

179.2

1084

3761

A04AA01

ATC

ondansetron; systemic, rectal

3.5

177.8

931

2902

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

176.6

169

176

Kela drug reimbursment

Regorafenib

120.6

174.8

189

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

224.2

170.8

176

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

345.5

169.8

171

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.1

169.8

710

1826

XX3DW

NOMESCO Finland

Time consuming IT work

2.7

168.5

1310

5330

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.1

166.7

364

413

SPAT1125

SPAT

Stoma care and guidance

7.4

165.8

415

586

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

162.1

1004

3524

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

239.9

160.8

165

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

159.1

2281

12553

1XC07

NOMESCO Finland

69.0

158.5

183

C18

ICD-10 Finland

Malignant neoplasm of colon

530.3

158.3

157

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

12.5

157.4

291

239

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

229.6

153.6

158

N02BE01

ATC

paracetamol; systemic, rectal

2.1

151.2

7766

66698

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.6

149.6

403

631

JFB00

NOMESCO Finland

Partial resection of small intestine

6.9

145.3

382

578

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.7

144.1

675

1911

JJB10

NOMESCO Finland

Atypcal resection of liver

54.7

143.7

172

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

141.0

135

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

141.0

1081

4330

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

137.8

132

ZX095

NOMESCO Finland

Combined chemoradiotherapy

15.0

136.6

233

159

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

35.6

136.5

178

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

132.5

3498

23681

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

11.9

128.6

243

209

K56.7

ICD-10 Finland

Ileus, unspecified

6.1

128.5

366

616

Z93

ICD-10 Finland

Artificial opening status

37.5

125.8

162

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

20.0

125.4

192

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.1

124.6

756

2598

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.2

122.3

713

2382

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.2

121.5

706

2350

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

76.8

119.6

136

L01XE21

ATC

[U] regorafenib; oral

140.8

117.4

125

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

115.7

1149

5260

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.0

115.0

494

1292

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

570.1

114.2

113

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

26.9

113.9

159

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.6

112.5

542

1563

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

111.7

107

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

169.2

111.5

117

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

110.8

1305

6471

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

21.3

108.8

163

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

279.5

108.1

110

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

1040.3

105.5

103

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.8

103.2

308

549

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.4

102.9

399

947

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

102.3

E0000UV

ATC

1.7

102.2

3316

23333

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

101.9

431

1110

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

101.2

JAH01

NOMESCO Finland

Laparoscopy

3.7

100.2

474

1344

A04AD12

ATC

aprepitant; systemic

5.4

99.9

316

604

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

76.4

99.4

113

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

12.5

99.0

182

148

JGB36

NOMESCO Finland

Wide excision of rectum

173.5

98.4

103

WW500

NOMESCO Finland

Blood transfusion

3.2

97.1

544

1759

JFB50

NOMESCO Finland

Other resection of colon

26.4

95.0

133

Z43.3

ICD-10 Finland

Attention to colostomy

31.4

94.9

127

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

245.0

94.8

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.1

93.6

218

275

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

40.9

92.8

117

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

6.3

92.7

258

421

WX704

NOMESCO Finland

Intubation

2.6

92.2

741

3015

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

125.1

92.1

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

887.0

89.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.4

89.5

473

1463

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.0

89.2

374

955

B01AB04

ATC

dalteparin; parenteral

2.8

89.0

620

2316

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

88.2

344

821

JF2AB

NOMESCO Finland

Colongraphy with X-ray

21.4

87.9

131

A04AA55

ATC

palonosetron, combinations; systemic

4.3

87.6

340

807

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.7

87.5

261

465

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

86.8

2837

19770

ZXD05

NOMESCO Finland

Urgent procedure

1.6

86.2

2769

19203

R4110

NOMESCO Finland

Physiotherapy

1.7

86.1

2409

16079

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

31.5

86.0

115

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

426.5

85.2

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.8

85.0

295

625

A02BC02

ATC

pantoprazole; systemic

1.5

84.0

5677

47045

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

5.0

83.9

285

590

D99

ICPC

Disease digestive system other

7.7

83.8

202

269

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

287.6

83.7

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.9

83.2

242

418

Z43.2

ICD-10 Finland

Attention to ileostomy

50.5

82.7

100

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.6

81.9

656

2657

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

8.9

81.5

179

205

SPAT1262

SPAT

Handing over of treatment supplies

1.7

81.4

1858

11644

Z31.5

ICD-10 Finland

Genetic counselling

3.7

80.5

373

1038

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

27.8

79.8

110

D18

ICPC

Change in faeces/bowel movements

4.3

79.0

305

720

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.1

78.4

321

801

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

78.4

1224

6735

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.7

78.2

278

604

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

78.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

77.8

4091

31764

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

11.2

77.1

149

135

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

75.9

1701

10570

JFB40

NOMESCO Finland

Resection of transverse colon

28.4

75.9

104

Z93.2

ICD-10 Finland

Ileostomy status

17.7

75.0

119

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

32.3

74.6

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

157.3

74.1

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

132.8

74.0

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

20.2

73.9

112

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.8

73.2

174

227

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

73.0

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

365.2

72.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

72.3

560

2221

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

20.4

72.2

109

L01BC53

ATC

tegafur, combinations; systemic

44.9

72.1

JAL30

NOMESCO Finland

Omentectomy

6.7

71.4

189

289

V03AF03

ATC

calcium folinate; systemic

24.9

71.1

101

UJF34

NOMESCO Finland

Left colonoscopy

8.1

71.0

165

208

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

9.5

69.8

147

157

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

344.8

68.6

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

235.0

68.3

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

68.2

427

1485

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

9.9

68.1

140

143

ZXC96

NOMESCO Finland

Robot assisted procedure

3.4

67.8

349

1057

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

61.3

67.6

K92.1

ICD-10 Finland

Melaena

2.4

67.4

639

2825

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

67.3

819

4063

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

53.1

66.0

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

117.5

64.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

63.5

577

2495

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.6

63.2

231

517

JKA20

NOMESCO Finland

Cholecystectomy

3.0

63.1

382

1299

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.6

63.1

296

832

A79

ICPC

Malignancy NOS

4.7

63.0

223

483

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.2

62.9

351

1128

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

622.4

62.9

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

62.6

JJB71

NOMESCO Finland

Laparoscopic resection of liver

40.8

61.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

4.6

61.0

222

495

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

34.6

60.7

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

9.8

59.6

123

127

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

58.9

1556

10057

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

581.8

58.7

6404

FHL

Hemicolectomy on the right

30.2

58.0

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

58.0

650

3104

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.5

57.4

280

813

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

57.3

JFF26

NOMESCO Finland

Sigmoidostomy

24.7

57.1

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

57.0

352

1212

JJB30

NOMESCO Finland

Excision of two segments of liver

42.0

56.9

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

24.0

56.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

56.2

464

1903

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

55.6

214

505

6434

FHL

Anterior resection

24.1

55.3

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

283.2

55.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.7

55.1

256

715

TPX15

NOMESCO Finland

Removal of vascular injection port

10.9

55.0

107

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.7

54.9

162

286

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

5.6

54.3

163

294

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.4

54.2

278

839

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

54.2

588

2764

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

36.6

53.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

53.5

3254

25376

JFF13

NOMESCO Finland

Terminal enterostomy

19.9

53.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

53.3

519

2319

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

75.6

53.0

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

84.9

52.9

JEA00

NOMESCO Finland

Appendectomy

2.3

52.6

508

2259

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

52.2

2547

18981

R4190

NOMESCO Finland

Nutritional therapy

3.1

52.2

299

979

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.6

51.5

184

403

JFB20

NOMESCO Finland

Ileocaecal resection

8.8

51.4

112

128

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

17.4

51.0

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

36.3

50.6

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

490.5

49.4

JFF24

NOMESCO Finland

Laparoscopic transversostomy

39.0

49.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

49.0

1156

7197

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

48.9

304

1051

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

53.0

48.6

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

47.9

D77

ICPC

Malignant digestive neopl other/NOS

9.7

47.9

103

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

+∞

46.9

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.1

46.9

189

467

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

12.4

46.7

1XC08

NOMESCO Finland

460.1

46.3

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

46.3

420

1812

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

16.9

46.2

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

13.4

46.0

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

45.9

412

1767

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

44.8

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.0

44.8

147

295

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

7.3

44.7

110

153

WX110

NOMESCO Finland

Local anesthesy

1.4

44.6

5059

43500

JJB20

NOMESCO Finland

Excision of single segment of liver

45.2

44.1

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

43.8

S18

ICPC

Laceration/cut

1.4

42.8

3546

28875

WF004

NOMESCO Finland

Palliative radiotherapy

3.1

42.5

246

813

6435

FHL

Abdominoperineal resection and colostomy

78.8

41.9

Z3231

NOMESCO Finland

Registered nurse

1.4

41.8

2286

17270

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

147.3

41.8

K65.0

ICD-10 Finland

Acute peritonitis

4.2

41.6

165

402

R50.9

ICD-10 Finland

Fever, unspecified

1.6

41.4

1144

7416

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.7

41.2

143

305

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

40.7

686

3833

JFA42

NOMESCO Finland

Endoscopic injection in colon

9.2

40.6

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

26.8

40.6

SPAT1153

SPAT

Removal of sutures

1.4

40.6

2738

21473

P01AB01

ATC

metronidazole; oral, rectal

1.4

40.5

2836

22381

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.8

40.3

266

959

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

13.6

40.1

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

13.0

39.9

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

200.8

38.8

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.2

38.8

212

673

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

+∞

38.6

1533A

ICD-9 Finland

Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]

+∞

38.6

JFC10

NOMESCO Finland

Ileotransversostomy

33.5

38.4

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.9

38.1

163

426

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

195.8

37.8

ZX121

NOMESCO Finland

Central venous catheter

9.8

37.7

WX002

NOMESCO Finland

Sedation and analgesia

1.5

37.6

1662

11999

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

26.1

37.5

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

37.5

K56.0

ICD-10 Finland

Paralytic ileus

4.3

37.5

144

341

WX882

NOMESCO Finland

High dependency care

2.6

37.2

277

1074

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

37.2

674

3856

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

61.7

37.1

8070/3-C20.9

ICD-O-3

Squamous cell carcinoma, NOS, of rectum, NOS

+∞

36.5

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

5.5

36.4

110

202

D16

ICPC

Rectal bleeding

3.0

36.0

213

713

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.5

36.0

132

299

C209

ICD-10 Finland

358.7

36.0

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

7.6

35.7

113

TJG20

NOMESCO Finland

Transanal irrigation

15.2

35.6

8000/3-C20.9

ICD-O-3

Neoplasm, malignant of rectum, NOS

+∞

35.4

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

34.9

243

906

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

34.7

2001

15172

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

10.2

34.6

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

6.5

34.4

141

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

15.4

33.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

6.0

33.2

156

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

10.4

32.9

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

6.8

32.8

125

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

30.8

32.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

32.5

509

2766

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

6.1

32.3

146

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

18.9

32.1

J01MA12

ATC

levofloxacin; systemic

1.4

32.1

1624

11996

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

61.9

32.0

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.8

31.8

215

787

JFF30

NOMESCO Finland

Other colostomy

16.0

31.5

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.8

31.4

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

16.2

31.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

31.0

651

3894

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

6.9

30.6

112

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

12.3

30.4

8480/3-C18.3

ICD-O-3

Mucinous adenocarcinoma of hepatic flexure of colon

+∞

30.2

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.8

30.0

131

350

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.7

30.0

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.4

30.0

254

1058

R11

ICD-10 Finland

Nausea and vomiting

1.7

30.0

616

3661

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

29.9

633

3794

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

32.6

29.9

L03AA02

ATC

filgrastim; parenteral

2.4

29.7

259

1097

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

4.9

29.1

200

SPAT1131

SPAT

Colonoscopy

2.2

28.9

305

1415

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

28.0

28.8

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

28.6

532

3066

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

17.7

28.2

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

39.1

28.0

3AC01

NOMESCO Finland

3.8

27.7

119

314

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.9

27.3

114

294

8000/3-C18.9

ICD-O-3

Neoplasm, malignant of colon, NOS

+∞

27.1

A06AH03

ATC

naloxegol; oral

3.4

27.0

132

388

JAQ10

NOMESCO Finland

Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity

140.4

26.6

N03AX16

ATC

pregabalin; oral

1.4

26.6

1775

13712

WF002

NOMESCO Finland

Radical radiotherapy

1.8

26.3

464

2626

D01.0

ICD-10 Finland

Carcinoma in situ: Colon

51.8

26.2

Z51.0

ICD-10 Finland

Radiotherapy session

3.1

26.0

143

459

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

25.8

761

4988

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

25.3

1286

9465

B80

ICPC

Iron deficiency anaemia

2.8

25.2

171

628

LCD00

NOMESCO Finland

Hysterectomy

2.1

25.2

302

1482

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

8.5

25.2

JFH10

NOMESCO Finland

Total colectomy and ileostomy

9.3

25.1

8480/3-C19.9

ICD-O-3

Mucinous adenocarcinoma of rectosigmoid junction

+∞

25.0

KCD10

NOMESCO Finland

Partial cystectomy

17.0

24.8

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

250.8

24.7

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

250.8

24.7

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.1

24.7

291

1418

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

5.8

24.2

120

JMA10

NOMESCO Finland

Transabdominal total splenectomy

5.0

24.0

158

8243/3-C18.1

ICD-O-3

Goblet cell carcinoid of appendix

+∞

24.0

1536A

ICD-9 Finland

Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]

+∞

24.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

23.9

439

2519

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.7

23.8

167

627

D48.42

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum originating in the appendix

67.6

23.8

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

240.5

23.6

ZXE00

NOMESCO Finland

One hour or less

1.3

23.3

2962

25007

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

33.4

23.3

L01EX05

ATC

regorafenib; oral

46.8

23.3

JJA20

NOMESCO Finland

Open biopsy of liver

7.8

23.1

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.2

23.0

122

383

JFC20

NOMESCO Finland

Other enterocolostomy

22.1

22.9

SPAT1109

SPAT

Analgesia with portable analgesic pump

4.3

22.7

195

R18

ICD-10 Finland

Ascites

2.5

22.7

175

696

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.8

22.6

258

XQ902

NOMESCO Finland

Other photography

5.2

22.5

135

L03AA13

ATC

pegfilgrastim; parenteral

2.0

22.3

285

1437

N02AX02

ATC

tramadol; systemic, rectal

1.3

22.2

3382

29138

L01BC04

ATC

carmofur; oral

16.7

22.2

A06AD11

ATC

lactulose; oral

1.4

22.0

1334

10108

JAD10

NOMESCO Finland

Repair of incisional hernia

3.7

22.0

269

C18.82

ICD-10 Finland

Malignant overall tumor of colon carcinoma of adenoma

+∞

21.9

8210/3-C20.9

ICD-O-3

Adenocarcinoma in adenomatous polyp of rectum, NOS

+∞

21.9

C18.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of colon

+∞

21.9

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.2

21.8

118

377

WX892

NOMESCO Finland

Monitored bed care

1.6

21.7

624

4058

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.5

21.5

169

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

5.6

21.5

114

Z71.8

ICD-10 Finland

Other specified counselling

1.3

21.3

1489

11538

LEC00

NOMESCO Finland

Partial excision of vagina

17.4

21.3

Z3226

NOMESCO Finland

Physiotherapist

1.4

21.1

1391

10677

R03AC02

ATC

salbutamol; inhalant

0.8

20.9

2826

32797

8210/3-C18.7

ICD-O-3

Adenocarcinoma in adenomatous polyp of sigmoid colon

+∞

20.8

8144/3-C20.9

ICD-O-3

Adenocarcinoma, intestinal type of rectum, NOS

+∞

20.8

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.9

20.8

126

433

D28

ICPC

Limited function/disability (D)

6.3

20.7

C18.89

ICD-10 Finland

Malignant overall tumor of the colon other or unspecified histology

76.9

20.7

JFA68

NOMESCO Finland

Endoscopic insertion of prosthetic tube into colon

210.4

20.6

K62.1

ICD-10 Finland

Rectal polyp

3.2

20.4

107

334

JFH96

NOMESCO Finland

Other total colectomy

25.5

20.4

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.6

20.3

257

WGA11

NOMESCO Finland

Planning of pain management

10.9

20.1

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.7

19.9

382

2223

8244/3-C18.1

ICD-O-3

Mixed adenoneuroendocrine carcinoma of appendix

+∞

19.8

JN4DD

NOMESCO Finland

Scout CT scan of torso

8.8

19.8

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.4

19.6

171

725

QX9VV

NOMESCO Finland

29.0

19.6

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

200.4

19.6

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

5.8

19.5

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

8.9

19.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

19.5

1073

7984

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

10.0

19.3

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

9.1

19.3

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

3.4

19.2

274

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

19.2

324

1809

LAE10

NOMESCO Finland

Unilateral oophorectomy

6.9

19.1

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

20.1

19.0

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

7.1

19.0

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

34.4

18.9

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

18.5

268

1421

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

3.5

18.5

246

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

18.5

183

828

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.6

18.4

139

549

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

18.3

305

1694

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.3

18.2

286

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

17.5

18.2

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

14.3

18.0

NET99

NOMESCO Finland

Other operation on pelvis

32.9

17.9

E34.0

ICD-10 Finland

Carcinoid syndrome

6.5

17.9

GDB10

NOMESCO Finland

Wedge resection of lung

8.3

17.9

3049

Kela drug reimbursment

+∞

17.7

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

17.5

315

1796

15302

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Cacci

180.3

17.5

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

17.3

774

5541

ZX100

NOMESCO Finland

Oral

2.6

17.3

131

518

JFA70

NOMESCO Finland

Suture of small intestine

5.7

17.1

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

5.7

17.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

17.0

1072

13681

JFB96

NOMESCO Finland

Other partial excision of intestine

15.9

17.0

JFW98

NOMESCO Finland

Other transluminal endoscopic operation on intestine

50.1

17.0

JHA00

NOMESCO Finland

Anal or perianal incision

3.0

16.9

329

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

16.9

361

2170

K63.5

ICD-10 Finland

Polyp of colon

2.8

16.8

109

394

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

16.8

268

1471

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

14.0

16.7

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

4.3

16.7

146

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

16.7

8240/3-C18.0

ICD-O-3

Neuroendocrine tumor, NOS, of cecum

+∞

16.7

J01MA02

ATC

ciprofloxacin; systemic

1.2

16.5

3162

27672

JJA43

NOMESCO Finland

Destruction of lesion of liver

27.5

16.5

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

6.0

16.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

11.1

16.2

A28

ICPC

Limited function/disability NOS

1.3

16.2

1334

10556

D29

ICPC

Digestive symptom/complaint other

2.4

16.1

140

597

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

15.9

1115

8611

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.8

15.8

179

1XA03

NOMESCO Finland

60.1

15.7

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

8.3

15.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

4.3

15.7

137

1540A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]

+∞

15.6

8000/3-C18.7

ICD-O-3

Neoplasm, malignant of sigmoid colon

+∞

15.6

ZXC40

NOMESCO Finland

Use of ultrasound

3.8

15.6

176

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.6

15.5

110

422

UJH02

NOMESCO Finland

Anoscopy

1.8

15.4

289

1671

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

15.2

807

5957

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

15.2

1134

8842

KBH20

NOMESCO Finland

Replantation of ureter

8.3

15.2

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

15.2

142

629

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

17.7

15.1

NK6LA

NOMESCO Finland

Bone and joint kinetic X-ray examination

9.4

14.9

M25.5

ICD-10 Finland

Pain in joint

0.8

14.8

1165

14476

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.9

14.8

298

D50

ICD-10 Finland

Iron deficiency anaemia

2.4

14.6

121

505

8000/3-C18.2

ICD-O-3

Neoplasm, malignant of ascending colon

+∞

14.6

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

4.2

14.6

128

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

5.4

14.6

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

12.5

14.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.8

14.3

250

1416

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4366

25882

2.23

315.96

2.9

2.6

u/l

55.4

59.3

4.98

4168

23703

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2405

7624

3.85

307.65

2.5

2.1

g/l

0.2

0.88

2323

7004

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2157

2848

9.41

307.65

6.0

2.8

u/ml

1493.8

2480.3

0.42

1951

2397

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3864

19810

2.56

307.65

3.1

2.5

—

(4035726)

2169

7030

3.67

307.65

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7070

8046

28.45

307.65

9.5

2.6

ug/l

32.7

23.3

0.87

6510

6464

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1129

1684

7.44

307.65

5.5

2.7

u/ml

154.4

801.4

2.95

1026

1533

(3022145) Colonoscopy Study observation

3572

8090

6.35

307.65

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2186

8987

2.84

307.65

3.0

2.7

umol/l

9.2

9.4

0.15

2008

7792

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6881

43120

2.97

307.65

14.5

5.9

umol/l

11.6

12.1

2.27

6720

40761

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6236

37127

2.85

307.65

5.6

4.2

—

(3044640) Blood type and Crossmatch panel - Blood

4856

25976

2.71

307.65

3.3

2.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

6248

37173

2.86

307.65

10.3

4.6

g/l

33.2

34.8

80.44

6020

34132

(3032080) INR in Blood by Coagulation assay

5673

36988

2.26

307.65

9.5

10.8

inr

1.2

1.3

10.98

1492

10045

(3037121) Protein [Mass/volume] in Urine

988

2852

3.74

290.73

6.2

2.6

g/l

0.2

0.3

12.57

756

1096

(3023368) Bacteria identified in Blood by Culture

4215

25405

2.15

284.11

5.1

4.4

—

(3033658) Prothrombin time (PT) actual/Normal

3626

20627

2.20

283.17

5.3

4.0

87.8

85.2

8.04

3587

20107

(40768804) Tissue Pathology biopsy report

4867

31145

2.11

278.54

2.8

2.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6354

45090

2.15

274.52

16.6

8.6

e9/l

4.0

4.3

23.12

5779

38966

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1738

7320

2.67

266.02

2.5

2.4

u/l

34.3

55.1

1.08

1614

6188

(3014576) Chloride [Moles/volume] in Serum or Plasma

2261

11469

2.26

226.08

9.2

6.7

mmol/l

105.0

104.4

8.54

2224

11212

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7802

62283

2.21

217.87

15.9

7.5

u/l

92.1

80.3

35.72

7573

58239

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2291

12268

2.13

196.42

2.2

2.7

18.3

21.8

28.26

2013

10271

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2386

13042

2.09

193.35

2.2

2.6

g/l

2.4

2.3

26.62

2272

11942

(3022948) Iron [Moles/volume] in Serum or Plasma

2506

14054

2.05

188.78

2.3

2.6

umol/l

10.7

12.3

21.06

2371

12861

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1427

6442

2.42

183.59

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3509

22322

1.89

181.20

2.4

2.3

mg/l

3.9

3.0

41.70

3036

18810

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3686

24032

1.85

174.48

4.7

3.2

u/l

36.7

35.9

0.11

3545

22591

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2760

16461

1.94

171.68

9.2

2.9

mmol/l

2.5

10.43

2587

14229

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

429

986

4.50

170.70

2.0

2.4

u/ml

224.4

660.6

0.70

422

968

(3013826) Glucose [Moles/volume] in Serum or Plasma

6353

49422

1.80

160.72

6.0

4.9

mmol/l

6.9

1.91

6120

46457

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2402

14119

1.93

153.30

5.2

3.0

mmol/l

0.8

16.36

2295

13036

(3015377) Calcium [Moles/volume] in Serum or Plasma

4088

28749

1.72

140.86

7.9

3.2

mmol/l

2.3

2.4

2.09

3731

24434

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

853

3418

2.64

139.49

2.6

2.8

u/ml

0.3

3.62

495

1956

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1085

4961

2.33

133.13

8.8

9.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5621

43555

1.67

130.61

8.3

6.8

mmol/l

1.2

30.79

4754

36380

(3003694) ABO and Rh group [Type] in Blood

2917

19084

1.75

127.24

1.4

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5171

39562

1.64

123.16

7.3

6.1

mmol/l

1.2

21.84

4795

35397

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1604

8811

1.98

121.79

8.2

7.7

g/l

115.7

120.6

21.14

1556

8481

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4245

31204

1.63

116.35

2.9

ug/l

135.4

159.8

3.65

3902

28187

(3016502) Oxygen saturation in Arterial blood

1709

9738

1.91

115.89

7.9

7.2

96.6

95.3

16.00

1654

9335

(40758558) Short blood count panel - Blood

2944

19855

1.69

112.06

12.8

6.5

—

(3003396) Base excess in Arterial blood by calculation

1817

10820

1.83

106.32

7.6

6.9

mmol/l

0.8

1.1

2.25

1480

8376

(3027801) Oxygen [Partial pressure] in Arterial blood

1812

10853

1.82

103.76

7.7

6.9

kpa

13.9

11.9

41.94

1741

10274

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1812

10860

1.82

103.52

7.7

6.9

kpa

5.1

2.86

1745

10301

(3002256) Pathology report gross observation

1776

10601

1.82

102.75

1.4

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1955

12060

1.77

101.07

2.2

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1425

7995

1.91

100.00

6.1

6.6

mmol/l

1.3

1.4

1.10

1367

7679

(3002582) Erythrocytes [#/volume] in Urine

3592

26502

1.56

89.82

3.6

3.5

e6/l

72.4

108.5

1.17

2945

20604

(3020779) Urea [Moles/volume] in Serum or Plasma

1442

8405

1.84

88.97

5.4

6.9

mmol/l

9.6

11.1

11.55

1376

7930

(3031040) Bacteria [#/volume] in Urine by Automated count

6419

53962

1.54

86.03

5.0

e6/l

2290.7

1669.9

0.26

865

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

315

970

3.32

82.24

4.2

3.3

nmol/l

7.2

12.3

0.39

308

945

(3026782) Osmolality of Urine

2528

17534

1.59

80.91

3.1

2.9

mosm/kgh2o

542.9

552.1

1.35

2238

14868

(3000991) Gas panel - Venous blood

1289

7548

1.81

77.54

7.2

8.0

—

(3030467) Casts [#/volume] in Urine by Automated count

3269

24315

1.51

75.27

3.6

3.3

e6/l

0.5

0.14

2636

18553

(36304419) Bacteria [Presence] in Urine

3136

23260

1.51

72.55

3.5

3.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

602

2756

2.26

72.20

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

4558

36591

1.46

69.90

5.0

5.9

2.7

2.9

5.77

4238

33714

(3019069) Monocytes/100 leukocytes in Blood

4578

36792

1.46

69.75

5.2

6.3

9.0

8.9

2.27

4257

34027

(3002030) Lymphocytes/100 leukocytes in Blood

4642

37476

1.45

68.62

5.2

6.1

23.4

26.3

50.43

4285

34439

(3022096) Basophils/100 leukocytes in Blood

4443

35605

1.45

68.14

5.0

6.0

0.6

0.7

19.70

4125

32836

(3039000) Anion gap in Blood

480

2064

2.39

66.50

8.3

6.8

mmol/l

11.1

11.3

0.79

438

1838

(3018572) Chloride [Moles/volume] in Blood

480

2064

2.39

66.50

8.3

6.8

mmol/l

106.3

104.9

8.41

438

1838

(3018095) Leukocytes [#/volume] in Urine

3839

30062

1.45

65.82

4.2

3.9

e6/l

130.5

112.0

0.65

3049

21965

(42870588) Differential panel, method unspecified - Blood

3567

27572

1.46

65.35

4.6

5.7

—

(3000850) Epithelial cells [#/volume] in Urine

2569

18711

1.50

63.03

2.8

2.7

e6/l

5.4

4.6

1.85

2286

16343

(3018010) Neutrophils/100 leukocytes in Blood

4539

36893

1.43

62.41

4.9

5.9

60.6

58.4

23.25

4224

34061

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1005

5826

1.81

61.68

8.7

8.6

0.7

0.61

999

5784

(3025941) Bacteria identified in Stool by Culture

741

3920

1.96

60.41

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

13.73

60.40

1.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

747

3985

1.95

59.39

1.9

ug/l

1.9

2.3

0.53

670

3461

(3047181) Lactate [Moles/volume] in Blood

583

2846

2.11

59.32

7.6

6.0

mmol/l

1.4

1.3

1.21

523

2505

(3006315) Basophils [#/volume] in Blood

4746

39149

1.41

58.57

4.7

5.6

e9/l

0.0

12.07

4052

33320

(3001604) Monocytes [#/volume] in Blood

4709

38903

1.40

56.98

4.7

5.6

e9/l

0.6

0.56

4014

33064

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

989

5855

1.77

56.27

8.7

8.5

1.3

1.4

2.04

983

5815

(3026008) Bacteria identified in Urine by Culture

3420

26781

1.42

56.03

3.4

—

(3019198) Lymphocytes [#/volume] in Blood

4795

39861

1.39

55.25

4.9

5.7

e9/l

1.7

1.9

2.67

4169

34491

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

730

3972

1.90

54.57

6.5

5.0

1.6

0.29

684

3717

(3007930) Methemoglobin/Hemoglobin.total in Blood

722

3921

1.91

54.28

6.7

5.1

0.9

2.46

675

3670

(3013115) Eosinophils [#/volume] in Blood

4839

40365

1.39

54.20

4.9

5.8

e9/l

0.2

7.37

4203

34809

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

460

2134

2.21

53.20

2.0

2.4

g/l

3.7

3.6

0.25

450

2026

(3008152) Bicarbonate [Moles/volume] in Arterial blood

992

6034

1.72

51.03

8.7

6.9

mmol/l

24.4

24.6

0.48

939

5610

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8286

76330

1.53

50.76

28.6

16.8

mg/l

36.9

26.4

114.31

7681

62159

(3037467) Urinalysis macro (dipstick) panel - Urine

6304

55246

1.39

50.67

5.6

4.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1687

11709

1.53

50.41

4.7

5.6

mmol/l

1.0

1.57

1572

10760

(40768441) Liver Pathology biopsy report

177

518

3.46

50.13

1.1

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1609

11111

1.54

49.09

2.0

2.4

1.8

0.29

1422

9689

(3019060) Gas panel - Arterial blood

1039

6474

1.68

48.74

6.4

4.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

836

4923

1.76

48.14

8.6

8.7

mmol/l

24.0

24.3

3.12

807

4534

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

873

5246

1.73

46.76

6.8

6.9

mmol/l

24.6

24.8

0.72

867

5193

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1931

14012

1.47

45.96

3.4

3.1

e6/l

2.7

2.1

1.80

1164

7839

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5372

46303

1.35

45.28

3.7

3.1

u/l

70.2

54.5

13.51

5033

42042

(3018418) pH of Serum or Plasma

3234

25902

1.37

43.38

4.9

4.1

7.4

1.57

696

4887

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

565

3063

1.90

42.50

2.7

4.0

u/ml

55.0

77.3

1.55

550

2937

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

398

1915

2.12

41.92

2.0

2.4

215.4

204.3

1.60

383

1808

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

417

2101

2.03

38.81

2.0

2.1

83.4

88.8

4.56

407

1972

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

785

4857

1.67

37.44

2.6

2.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1858

13935

1.41

35.82

2.0

30.1

0.05

1814

13499

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1994

15192

1.39

34.95

1.8

1.9

—

(3012544) pH of Venous blood

1279

9010

1.48

34.40

3.3

3.8

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1241

8710

1.49

33.97

3.3

3.8

kpa

5.7

5.8

7.04

1201

8449

(3002032) Base excess in Venous blood by calculation

1233

8673

1.48

33.34

3.3

3.8

mmol/l

1.8

1.9

0.12

956

7051

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

357

1812

2.01

32.55

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1283

9208

1.45

31.13

4.8

3.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1942

15085

1.36

29.50

3.2

2.9

e6/l

1.2

1.3

0.40

1162

8838

(3023520) Reticulocytes [#/volume] in Blood

1178

8425

1.45

28.98

2.1

2.5

e9/l

69.2

68.4

0.29

914

6451

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

255

1193

2.17

28.91

5.8

6.4

mg/l

11.9

12.1

0.21

226

1076

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

236

1077

2.22

28.47

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

230

1051

2.22

27.67

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

228

1047

2.21

27.10

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

230

1062

2.19

26.97

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

227

1048

2.19

26.64

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

227

1051

2.19

26.45

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

207

931

2.25

25.90

1.1

g/l

1.6

1.5

1.41

195

832

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

438

2562

1.74

25.58

1.8

1.7

—

(3036489) Thrombin time

453

2707

1.71

24.49

1.9

21.2

21.9

1.82

428

2401

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1425

10847

1.37

24.13

3.1

4.1

u/l

249.9

248.5

0.10

1358

10166

(3019550) Sodium [Moles/volume] in Serum or Plasma

8439

80247

1.36

23.97

34.1

19.9

mmol/l

139.2

139.6

34.81

8302

78124

(3023103) Potassium [Moles/volume] in Serum or Plasma

8448

80397

1.35

23.44

34.1

20.1

mmol/l

4.0

24.55

8301

78153

(3019225) pH of Specimen

1214

9066

1.39

23.07

4.6

4.5

—

(3013512) EKG study

3054

25926

1.26

22.80

4.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

369

2144

1.75

22.08

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

366

2126

1.75

21.93

1.2

—

(3021589) Normoblasts [#/volume] in Blood

3892

34079

1.23

21.64

15.4

10.2

e9/l

0.0

1.04

3182

27781

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

784

5476

1.47

21.56

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

368

2153

1.74

21.50

1.2

—

(40761511) CBC panel - Blood by Automated count

8194

77861

1.31

21.25

28.9

16.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1036

7664

1.39

20.72

1.7

2.1

ug/g

260.4

154.3

8.41

811

5928

(3051651) Icteric interference index of Serum or Plasma

128

515

2.50

20.67

5.8

3.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

633

4270

1.52

20.65

3.0

4.1

mmol/l

23.9

24.1

0.95

579

3807

(4281824)

169

778

2.19

20.08

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1275

9807

1.34

19.89

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7586

71554

1.26

19.77

29.1

15.9

ml/min/173m2

76.5

74.0

22.72

6838

59413

(40768797) Stomach Pathology biopsy report

1417

11110

1.32

19.34

1.2

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6932

73504

0.81

19.29

4.3

4.7

mmol/l

1.4

0.88

6175

66182

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7004

74183

0.81

19.26

4.3

4.8

mmol/l

4.5

0.37

6291

67288

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

885

11840

0.72

18.28

1.2

1.3

iu/ml

49.3

38.2

1.08

290

3613

(3024354) Oxygen [Partial pressure] in Venous blood

963

7183

1.38

18.23

3.0

3.2

kpa

4.5

0.41

924

6934

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1690

20561

0.79

17.45

1.7

1.6

mmol/l

1.4

1.3

3.43

1396

16922

(3023183) Ammonium ion [Moles/volume] in Plasma

303

1784

1.72

17.36

2.2

2.5

umol/l

32.3

33.9

0.59

255

1468

(3018405) Lactate [Moles/volume] in Arterial blood

506

3394

1.52

16.96

4.9

4.0

mmol/l

1.3

1.4

1.09

495

3334

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

568

3907

1.48

16.84

1.9

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2230

18786

1.24

16.80

1.8

nmol/l

1180.6

1156.4

0.51

1697

13909

(3052851) Hemolysis interference index of Serum or Plasma

416

2682

1.58

16.67

4.9

3.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

652

4619

1.44

16.58

1.5

1.6

g/l

1.8

1.6

5.62

561

3915

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

189

3.24

16.05

2.0

2.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

842

11121

0.73

15.85

1.2

u/ml

18.5

14.5

0.57

312

3964

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

972

7422

1.34

15.75

4.6

3.9

mmol/l

1.2

1.93

880

6409

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8381

80501

1.27

15.69

36.3

19.8

umol/l

82.1

83.5

2.63

8376

80473

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6824

72023

0.83

15.40

6.4

6.5

mmol/mol

41.3

40.8

2.88

6123

65466

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7262

76163

0.82

15.11

4.8

5.4

mmol/l

2.6

1.30

6469

68778

(3033799) Differential panel - Peritoneal fluid

273

2.76

14.92

1.6

2.0

—

(3012501) Base excess in Blood by calculation

334

2109

1.60

14.66

4.4

4.3

mmol/l

2.7

2.6

0.14

241

1437

(3013290) Carbon dioxide [Partial pressure] in Blood

334

2111

1.60

14.60

4.4

4.3

kpa

5.0

0.01

328

2058

(3044889) 12 lead EKG panel

6023

56144

1.19

14.59

4.5

4.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

516

3592

1.46

14.41

1.9

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

178

947

1.90

14.35

5.1

3.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8355

80387

1.26

14.33

19.0

11.1

u/l

24.8

25.6

3.14

8163

76882

(3027315) Oxygen [Partial pressure] in Blood

334

2124

1.59

14.24

4.4

4.3

kpa

9.0

8.4

4.12

328

2070

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1304

10518

1.28

14.04

1.7

1.8

—

(3020891) Body temperature

536

3780

1.44

13.98

5.6

4.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

419

2830

1.50

13.62

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

6965

65908

1.19

13.62

30.8

18.2

37.0

38.9

35.01

4399

41759

(3010421) pH of Blood

370

2435

1.54

13.59

4.2

7.4

0.06

328

2059

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3808

34285

1.18

13.59

3.9

4.1

ng/l

40.1

82.6

2.12

3060

26113

(40761536) Microorganisms panel - Urine sediment

869

6707

1.32

13.02

4.5

4.3

—

(3002385) Erythrocyte distribution width [Ratio]

6437

60653

1.18

12.62

37.6

20.3

14.7

13.9

201.64

6355

59198

(3021162) Amylase [Enzymatic activity/volume] in Specimen

150

3.21

12.54

2.4

2.8

u/l

724.2

1990.1

0.82

140

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6776

71159

0.85

12.37

3.9

4.2

mmol/l

1.3

3.79

5990

63449

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

753

5735

1.34

12.36

1.8

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

631

4682

1.37

12.27

3.6

3.5

mmol/l

24.6

25.2

3.05

610

4549

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1282

10502

1.25

12.01

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

852

6651

1.31

11.75

4.1

2.7

ml/min/173m2

63.0

60.9

0.91

378

2757

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2044

17606

1.20

11.74

3.7

4.1

ng/l

483.5

498.1

0.03

1716

14964

(3022217) INR in Platelet poor plasma by Coagulation assay

1597

13432

1.23

11.70

24.4

29.7

inr

1.4

1.5

2.09

258

1779

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

126

647

1.96

11.39

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

450

2.14

11.11

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

450

2.14

11.11

1.3

1.4

—

(1616796) Gas panel - Central venous blood

314

2088

1.52

11.06

3.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

633

1.95

11.06

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

287

1877

1.54

10.92

1.2

titre

59.4

174.1

2.33

156

(3004119) Hemoglobin [Mass/volume] in Venous blood

739

5718

1.32

10.86

3.1

3.4

g/l

121.7

127.7

9.98

720

5577

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1656

14107

1.21

10.58

1.2

u/ml

1.9

0.01

415

3518

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5347

56838

0.87

10.18

3.5

3.9

pmol/l

15.0

0.24

4693

50620

(3043410) Blood group antigens tested for on Red Blood Cells

234

2.53

10.05

2.4

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1824

15811

1.19

9.54

4.1

4.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

309

2.27

9.45

1.4

2.2

e6/l

8754.4

5194.9

0.17

216

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

142

808

1.77

9.39

1.2

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

206

1305

1.59

9.08

1.9

1.8

ug/l

18.1

24.1

2.41

198

1270

(3024731) MCV [Entitic volume]

8514

82793

1.21

9.07

44.1

24.5

91.2

91.7

17.02

8408

81243

(3007461) Platelets [#/volume] in Blood

8512

82773

1.21

9.07

44.3

24.6

e9/l

250.7

241.1

27.61

8357

80233

(3026361) Erythrocytes [#/volume] in Blood

8514

82798

1.21

9.04

44.2

24.6

e12/l

4.3

4.4

155.64

8338

79933

(3000963) Hemoglobin [Mass/volume] in Blood

8515

82810

1.21

9.03

44.5

24.7

g/l

126.7

133.8

302.05

8408

81273

(3035941) MCH [Entitic mass]

8513

82790

1.21

9.02

44.0

24.4

30.1

30.5

62.58

8405

81237

(3037522) Nuclear Ab [Titer] in Serum

747

9320

0.79

8.99

1.3

titre

530.0

506.0

0.12

156

1983

(3034770) Mitochondria Ab [Titer] in Serum

277

1881

1.49

8.90

1.2

titre

401.7

899.2

—

(3010813) Leukocytes [#/volume] in Blood

8513

82815

1.20

8.85

44.3

24.6

e9/l

6.9

0.38

8347

79951

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3978

36742

1.14

8.73

2.1

pmol/l

88.0

93.6

11.52

2312

19180

(3043409) Potassium [Moles/volume] in Arterial blood

398

2900

1.39

8.73

5.5

4.3

mmol/l

3.8

3.9

6.28

372

2720

(3017181) Myelocytes/100 leukocytes in Blood

867

7046

1.25

8.64

3.3

4.0

1.0

0.29

340

2131

(3030981) Hyaline casts [#/volume] in Urine by Automated count

629

4920

1.30

8.56

3.2

2.9

e6/l

0.4

0.3

0.98

621

4827

(3021440) Promyelocytes/100 leukocytes in Blood

825

6687

1.25

8.41

3.2

4.0

0.2

0.1

0.31

315

1974

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

178

1112

1.61

8.35

2.1

3.7

u/ml

18.4

40.2

5.12

172

1075

(40767503) Oxygen content in Capillary blood by calculation

289

2006

1.45

8.34

2.6

15.3

15.9

1.36

139

1057

(3004809) Band form neutrophils/100 leukocytes in Blood

233

1550

1.52

8.30

2.6

3.6

2.4

1.5

2.10

182

1182

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

273

2.24

8.04

1.4

2.0

e6/l

17633.1

18088.5

0.01

153

(3041096) Erythrocytes [Presence] in Urine by Automated

2233

19920

1.16

7.98

4.5

3.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

318

2271

1.41

7.88

1.5

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7222

74749

0.87

7.77

4.7

5.1

mmol/l

6.2

6.1

4.96

6424

66754

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

277

1936

1.44

7.73

1.2

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

225

1510

1.50

7.72

3.0

3.2

e9/l

4.3

4.4

0.31

225

1505

(3028626) Oxygen [Partial pressure] in Capillary blood

297

2108

1.42

7.63

3.6

2.9

kpa

8.0

7.8

0.62

280

1933

(3013707) Erythrocyte sedimentation rate by Westergren method

6101

58164

1.13

7.52

3.7

4.3

mm/h

17.6

14.0

39.04

5521

53143

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

553

4333

1.29

7.46

2.5

2.7

0.7

0.28

535

4150

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

559

4391

1.29

7.40

4.2

4.1

48.2

47.5

0.33

554

4336

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

563

4428

1.29

7.38

2.6

2.7

1.1

1.2

1.06

557

4401

(3021901) Oxygen saturation in Capillary blood

258

1797

1.45

7.36

2.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2453

27051

0.88

7.25

2.1

2.2

u/l

235.3

221.9

0.26

2311

25198

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1913

17005

1.15

7.08

1.7

mg/l

2.0

1.4

5.70

1563

13240

(3044007) Cell count panel - Peritoneal fluid

244

2.22

7.00

1.6

2.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

772

6364

1.23

6.77

3.0

3.8

0.8

0.7

0.52

228

1533

(3009261) Glucose [Presence] in Urine by Test strip

4180

39153

1.12

6.64

4.3

4.1

estimate

0.0

2.20

919

6935

(3021601) Nitrite [Presence] in Urine by Test strip

4129

38677

1.12

6.51

5.7

5.3

estimate

0.0

0.33

931

7140

(40761539) Cells [Type] in Urine sediment by Light microscopy

220

2.23

6.48

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1018

8668

1.19

6.40

2.9

3.0

ng/l

227.0

241.6

0.52

927

7934

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

315

4211

0.74

6.40

1.3

au/ml

60.9

57.2

0.10

175

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

813

6778

1.22

6.39

1.3

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

283

2064

1.38

6.28

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

283

2064

1.38

6.28

1.2

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.24

6.26

2.2

62.0

66.7

0.26

(3020393) Adenovirus Ag [Presence] in Stool

3.24

6.26

1.1

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

763

6339

1.22

6.22

1.3

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2026

22423

0.88

6.15

2.7

2.9

umol/l

4072.2

5810.7

1.20

1745

18982

(3000570) Elastase.pancreatic [Mass/mass] in Stool

330

2476

1.34

6.13

1.4

ug/g

245.8

263.4

0.87

211

1506

(3026692) Albumin [Mass/volume] in Peritoneal fluid

228

2.15

5.97

1.1

1.6

g/l

14.6

13.6

0.40

177

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

510

1.75

5.91

2.3

1.7

—

(3013727) Leukocytes other/100 leukocytes in Blood

303

1.99

5.90

2.3

3.9

55.8

54.3

0.22

290

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

360

4662

0.76

5.86

2.4

au/ml

40.0

25.0

0.57

159

(1761482) Bacteria [#/volume] in Urine by Culture

345

2626

1.33

5.83

5.0

4.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

687

5693

1.22

5.75

3.7

3.6

mmol/l

1.9

1.8

0.12

492

4219

(3025159) Blasts/100 leukocytes in Blood

745

6224

1.21

5.75

3.3

4.0

0.3

0.4

0.18

250

1665

(3035350) Ketones [Presence] in Urine by Test strip

4107

38647

1.11

5.68

4.2

4.0

estimate

0.0

0.50

915

7075

(4010399)

477

5930

0.79

5.59

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

176

2522

0.69

5.51

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

448

1.77

5.47

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

448

1.77

5.47

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

448

1.77

5.47

1.4

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

471

1.75

5.44

1.8

1.9

u/field

2.5

1.8

0.44

317

(1002224) Polysomnography panel

147

2167

0.67

5.37

1.1

—

(1761868) Lipid panel - Serum or Plasma

2036

22356

0.89

5.33

3.0

3.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

599

7226

0.82

5.31

1.5

1.6

—

(3009343) pH of Capillary blood

704

5898

1.21

5.30

3.7

7.4

0.08

740

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

712

5979

1.21

5.23

3.7

kpa

5.1

5.2

2.53

663

5479

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

121

777

1.56

5.23

1.7

2.2

u/field

2.8

1.7

1.06

280

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

448

1.75

5.19

1.4

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1413

12551

1.15

5.19

1.4

1.5

g/l

2.7

2.6

0.03

791

7208

(3029937) Albumin [Presence] in Urine by Test strip

2332

21384

1.12

5.13

4.4

4.5

estimate

0.0

0.47

835

6761

(3021960) Folate [Moles/volume] in Serum or Plasma

2353

21593

1.12

5.10

1.6

nmol/l

20.3

20.1

0.25

2023

18261

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

639

0.42

5.10

1.0

ng/l

38.1

43.9

0.43

414

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

636

0.42

5.05

1.0

ng/l

672.2

706.0

0.21

411

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

635

0.42

5.03

1.0

ng/l

258.2

327.2

1.83

420

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

2615

0.72

4.87

1.1

1.2

u/ml

3.6

0.9

0.67

255

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3105

28978

1.10

4.85

2.8

3.2

ng/l

1642.6

1771.6

0.75

2687

25141

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

355

1.81

4.82

1.5

2.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

280

2134

1.32

4.76

1.3

1.6

—

(3019977) pH of Arterial blood

554

1.63

4.68

2.7

2.5

7.4

1.08

204

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

412

3308

1.26

4.68

2.0

2.2

ug/l

381.1

652.3

2.06

401

3130

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

139

944

1.48

4.68

2.7

3.1

—

(3000494) Fungus identified in Specimen by Culture

1045

9152

1.16

4.67

1.5

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6738

69403

0.91

4.65

4.3

4.8

mu/l

2.5

2.1

0.56

5924

62122

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

352

1.79

4.65

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

352

1.79

4.65

1.5

2.1

—

(4094501)

153

2164

0.70

4.52

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

290

2241

1.30

4.49

3.7

3.4

mmol/l

1.7

0.00

284

2189

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.95

4.27

2.3

2.1

17.0

13.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

181

1315

1.38

4.25

2.9

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

267

2061

1.30

4.19

1.3

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

490

5882

0.82

4.18

2.0

2.1

nmol/l

10.2

12.1

5.23

419

5069

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

366

2941

1.25

4.17

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

130

1860

0.69

4.14

1.4

1.7

mg/l

3.3

3.6

0.17

103

1354

(3045683) HLA typing for celiac disease panel - Blood or Tissue

285

1.83

4.12

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

103

1537

0.67

4.10

1.3

1.4

e6/l

228.8

1191.6

3.60

1253

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

103

1534

0.67

4.06

1.2

1.3

e6/l

18.5

24.6

0.21

1182

(4034850)

195

2599

0.75

4.02

14.2

11.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

209

1570

1.34

4.00

1.3

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

175

2364

0.74

3.95

1.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1272

0.64

3.95

1.1

1.2

u/ml

60.6

44.8

—

138

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

104

1536

0.67

3.95

1.2

mmol/l

3.9

0.07

1436

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

440

1.64

3.92

3.1

3.6

—

(3008898) HLA-B27 [Presence]

110

1600

0.68

3.86

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

152

2.11

3.82

2.9

4.4

u/l

64.1

40.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

271

2126

1.28

3.80

2.3

g/l

121.3

127.3

3.46

205

1529

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

330

1.73

3.80

2.4

2.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

257

2005

1.29

3.77

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

308

2459

1.26

3.75

3.0

3.1

mmol/l

24.1

24.9

2.34

272

2135

(3001893) Eosinophils/100 leukocytes in Pleural fluid

341

1.70

3.67

1.4

1.5

3.0

2.6

0.11

286

(3024891) Influenza virus A+B Ag [Presence] in Specimen

236

1832

1.30

3.61

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

212

1626

1.31

3.55

1.1

u/ml

5.3

11.3

0.94

128

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1843

19937

0.91

3.50

3.1

3.2

ug/l

0.8

0.18

1293

14205

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

323

3957

0.81

3.43

1.8

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2065

19176

1.10

3.41

1.7

pmol/l

8673005.1

28839989.2

2.18

1695

15451

(21494755) Public health laboratory ask at order entry panel

268

3346

0.80

3.39

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

627

0.54

3.29

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.38

3.22

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

239

1890

1.27

3.21

1.8

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

200

2567

0.77

3.20

1.5

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1032

0.65

3.20

3.6

4.3

umol/l

329.5

349.9

0.55

865

(3005322) IgE [Units/volume] in Serum or Plasma

318

3864

0.82

3.15

1.2

1.3

u/ml

215.5

244.5

0.30

288

3526

(3045424) Erythrocytes [Presence] in Urine

175

1337

1.31

3.07

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

108

765

1.42

3.05

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

108

765

1.42

3.05

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

108

765

1.42

3.05

1.4

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

567

1.49

3.05

1.6

1.9

u/l

268.3

1446.8

1.57

213

(3014271) Vancomycin [Susceptibility]

605

1.46

2.93

2.9

3.0

—

(3052592) Norovirus Ag [Presence] in Stool

198

1.82

2.92

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

134

1789

0.75

2.90

1.6

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

265

3242

0.81

2.84

1.2

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

407

1.55

2.83

1.4

1.5

55.1

67.2

1.62

334

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

728

8188

0.88

2.80

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

181

2306

0.78

2.78

1.4

1.6

—

(3012441) Differential panel - Pleural fluid

150

1140

1.32

2.77

1.4

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

284

0.39

2.72

1.1

1.8

ug/l

23.9

144.3

0.64

259

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2661

28054

0.93

2.67

4.3

4.7

21.6

22.2

1.16

1372

14841

(3022493) Free Hemoglobin [Mass/volume] in Plasma

360

1.56

2.60

1.5

4.4

mg/l

60.2

69.3

0.49

254

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3103

29582

1.07

2.59

4.7

4.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

543

0.57

2.58

1.2

1.1

—

(3022313) Gas panel - Capillary blood

493

4281

1.16

2.58

3.9

3.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

314

1.60

2.56

1.2

1.3

ug/l

1024.9

313.5

0.71

168

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.00

2.56

1.9

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

112

828

1.36

2.52

1.5

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

517

1.45

2.52

1.4

1.7

umol/l

81.8

69.9

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.82

2.47

1.1

1.2

u/field

1.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

449

1.47

2.39

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

449

1.47

2.39

1.3

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

187

1496

1.25

2.38

1.4

1.5

g/l

30.6

31.6

0.49

167

1321

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

169

2115

0.80

2.30

1.5

1.6

iu/ml

3.3

6.8

0.39

519

(3028707) Methadone [Presence] in Urine by Screen method

383

0.52

2.29

1.4

2.0

—

(3042733) HLA Ab [Presence] in Serum

186

0.38

2.26

2.4

4.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

116

880

1.32

2.24

1.5

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

201

1.69

2.23

1.2

1.4

g/l

26.8

27.1

0.04

157

(3000475) Leukocytes [#/volume] in Synovial fluid

173

2151

0.80

2.23

1.6

e6/l

14661.2

15238.0

0.07

130

1524

(1001926) Buprenorphine [Presence] in Urine by Screen method

618

0.63

2.23

1.3

1.7

—

(36660697) Celiac disease serology panel - Serum

571

5069

1.13

2.22

1.1

1.2

—

(36303858) Crystals [Presence] in Urine

5.56

2.21

1.0

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

217

2627

0.82

2.18

2.6

2.2

g/l

0.0

0.00

199

2386

(3011288) Drugs identified in Urine by Screen method

514

0.60

2.15

1.1

2.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

130

1009

1.29

2.14

1.3

u/l

805.5

407.6

0.37

122

954

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

411

0.56

2.12

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

104

1366

0.76

2.11

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

284

1.55

2.07

3.2

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

284

1.55

2.07

3.2

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

102

770

1.33

2.07

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

540

1.39

2.05

1.5

1.6

u/l

6.9

6.1

0.12

245

(3035880) pH of Pleural fluid

600

1.37

2.04

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

118

1.87

2.01

1.0

1.2

ng/l

103.9

799.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

139

1746

0.79

2.00

1.6

1.7

nmol/l

39.8

44.4

1.99

131

1661

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

1.79

2.00

1.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

2.81

2.00

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

123

962

1.28

1.95

2.6

3.5

59.5

58.3

0.19

610

(3000919) Neutrophils/100 leukocytes in Pleural fluid

305

1.51

1.94

1.4

25.2

17.9

1.01

276

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1087

0.74

1.94

1.2

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

487

1.40

1.93

2.1

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

124

973

1.28

1.92

1.3

—

(3017569) Oxygen content in Arterial blood

480

1.40

1.91

2.1

2.2

—

(3019150) Specific gravity of Urine by Refractometry

1640

17395

0.93

1.91

4.4

4.6

kg/l

1.0

0.08

290

2704

(3000492) Spirometry study

586

6507

0.89

1.90

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

712

1.32

1.89

1.0

1.1

u/ml

5.6

3.5

0.30

236

(3023199) Leukocytes [#/volume] in Pleural fluid

163

1324

1.23

1.88

1.4

1.5

e6/l

1015.0

2356.9

4.81

127

958

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

129

1020

1.27

1.88

1.3

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

319

0.53

1.88

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

125

1574

0.79

1.86

1.2

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

197

1.63

1.85

1.2

—

(3000330) Specific gravity of Urine by Test strip

521

4661

1.12

1.84

5.5

3.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

149

1202

1.24

1.84

1.4

1.5

e6/l

122615.5

56991.6

0.67

101

712

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

122

1538

0.79

1.84

1.1

—

(3028300) Cannabinoids [Presence] in Urine

809

0.72

1.80

1.2

1.7

—

(3049717) Cytology report of Urine Cyto stain

468

4168

1.13

1.79

2.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

324

3718

0.87

1.78

1.1

1.2

iu/ml

144.7

129.7

0.26

106

1305

(3020876) Protein [Mass/time] in 24 hour Urine

106

825

1.29

1.77

1.9

—

0.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.34

1.77

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

102

1.86

1.75

1.3

1.2

ug/l

44.4

116.6

4.65

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

461

0.63

1.75

1.2

1.4

pmol/l

123.7

125.7

—

142

(3044290) Cell count panel - Cerebral spinal fluid

109

1382

0.79

1.74

1.2

1.3

—

(40768443) Skin Pathology biopsy report

335

3828

0.87

1.74

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

448

0.62

1.74

1.5

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.50

1.73

1.0

1.1

nmol/l

195.6

270.3

—

(3027008) Opiates [Presence] in Urine

803

0.72

1.73

1.2

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

170

1.65

1.73

1.0

1.3

umol/l

1.9

3.0

2.49

153

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

171

1.64

1.69

1.5

11.5

9.1

0.15

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

413

3666

1.13

1.68

4.2

4.0

mmol/l

24.7

24.8

0.34

371

3329

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

228

2673

0.85

1.68

2.6

2.2

g/l

0.0

0.63

201

2395

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

114

903

1.27

1.68

1.1

1.2

u/l

92.6

62.1

0.86

589

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

178

2132

0.83

1.67

1.5

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

179

1491

1.20

1.66

3.2

5.0

iu/ml

335.7

2210.9

0.96

226

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

119

1.77

1.65

1.5

1.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

175

2094

0.83

1.64

1.3

1.5

g/l

0.2

0.29

165

1973

(3003181) Sodium [Moles/volume] in Urine

201

1695

1.19

1.63

1.4

1.3

mmol/l

58.0

62.3

0.76

141

1356

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

286

3286

0.87

1.63

2.5

2.3

g/l

0.9

1.0

0.19

238

2749

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.84

1.61

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.50

1.59

3.5

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.50

1.59

7.0

6.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

328

1.43

1.59

1.5

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

300

0.57

1.57

1.2

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

173

0.46

1.57

1.5

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

126

1019

1.24

1.57

2.9

4.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

439

1.37

1.56

1.1

u/l

87.7

95.5

0.33

331

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

183

2170

0.84

1.56

1.3

1.5

g/l

1.1

1.2

0.47

172

2046

(3047189) Immunofixation for 24 hour Urine

483

0.66

1.56

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

261

2261

1.16

1.54

3.1

nmol/l

0.8

0.20

203

1736

(3000764) Benzodiazepines [Presence] in Urine

797

0.74

1.54

1.2

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

154

1852

0.83

1.54

1.1

1.2

u/ml

43.0

41.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1022

0.77

1.52

1.6

1.7

—

(3016879) Cocaine [Presence] in Urine

748

0.73

1.51

1.2

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

146

1.65

1.50

1.8

ug/l

2.7

5.8

0.59

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

175

1471

1.19

1.50

2.9

3.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

477

1.34

1.50

2.4

2.3

—

(3024932) HLA-DR beta [Type]

184

0.49

1.49

1.2

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.49

0.0

11.5

—

203.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

248

2857

0.86

1.49

2.6

2.2

g/l

0.1

0.0

0.29

221

2571

(3006576) Bicarbonate [Moles/volume] in Blood

333

1.41

1.49

5.3

6.6

mmol/l

25.0

24.8

0.09

296

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

380

0.63

1.47

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

145

1744

0.83

1.47

1.1

1.2

u/ml

2.7

7.3

3.43

281

(3000012) Reticulocyte production index

557

1.31

1.46

1.2

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1038

0.78

1.46

1.1

1.2

miu/ml

149.6

205.6

0.74

367

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

104

1292

0.80

1.45

1.7

1.8

pmol/l

193.9

196.7

0.09

1192

(4027681)

304

0.59

1.44

1.3

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.73

1.43

1.2

1.0

u/ml

0.1

0.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

438

1.35

1.43

1.1

u/l

35.1

31.9

0.14

319

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

303

0.59

1.42

1.1

u/l

2.6

1.1

—

150

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

785

0.75

1.42

1.1

1.2

mmol/l

7.6

7.9

0.29

550

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

155

0.45

1.41

1.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

144

1725

0.83

1.41

1.1

1.2

u/ml

8.3

6.5

0.16

184

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

640

1.28

1.40

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

103

827

1.25

1.40

3.3

3.0

mg/l

53.8

47.6

0.09

611

(3037692) Legionella sp identified in Specimen by Organism specific culture

326

0.61

1.40

1.1

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

423

0.66

1.40

1.2

1.1

mg/l

43.2

44.0

0.04

359

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

350

0.63

1.39

1.2

1.1

ratio

1.1

—

111

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.80

1.36

1.9

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

467

0.68

1.35

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1047

11135

0.93

1.35

11.8

8.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

687

0.74

1.35

1.1

—

3.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

466

0.69

1.34

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

466

0.69

1.34

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

221

0.54

1.32

1.0

1.2

—

29.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

266

3014

0.88

1.30

2.4

2.1

g/l

37.1

37.2

0.10

212

2530

(3006270) Folate [Moles/volume] in Blood

101

818

1.24

1.29

1.3

1.2

nmol/l

317.0

333.7

0.33

630

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

232

0.56

1.29

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

784

0.76

1.29

1.2

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

355

0.65

1.29

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

462

0.69

1.29

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

462

0.69

1.29

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

461

0.69

1.28

1.1

—

(3024471) HLA-A [Type]

192

0.52

1.27

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

119

984

1.21

1.26

1.3

1.4

mmol/l

6.6

6.4

0.27

111

898

(40768795) Lymph node Pathology biopsy report

100

815

1.23

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

296

1.39

1.21

2.3

2.7

—

31.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

113

1361

0.83

1.21

1.3

1.4

—

(44813793)

397

0.68

1.21

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

557

1.28

1.21

2.4

2.6

—

(3045414) Leukocytes [Presence] in Urine

397

3600

1.11

1.20

2.2

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.31

1.18

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

2.50

1.15

1.0

2.1

—

(3017732) Neutrophils [#/volume] in Blood

568

5251

1.09

1.15

4.0

3.1

e9/l

4.0

4.2

0.66

422

3771

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

214

2434

0.88

1.14

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

352

1.34

1.13

1.1

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

721

0.78

1.12

1.3

—

(3024263) Appearance of Synovial fluid

471

0.72

1.12

1.6

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

283

2532

1.12

1.11

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

147

1257

1.17

1.11

1.3

1.5

—

(3021788) Differential panel - Synovial fluid

136

1595

0.85

1.10

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

129

1092

1.18

1.10

9.3

13.0

mmol/l

7.0

7.4

1.04

114

884

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

628

1.24

1.10

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

135

1148

1.18

1.09

1.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

256

0.62

1.08

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

112

1.61

1.08

2.6

u/field

0.8

0.4

0.88

112

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

570

0.75

1.07

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

121

1022

1.19

1.06

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

550

1.26

1.06

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

546

0.75

1.06

2.5

2.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

640

6856

0.93

1.06

2.3

—

(3004451) EKG impression Narrative

498

1.27

1.04

1.3

—

(3015736) pH of Urine

3135

30528

1.04

3.9

3.8

5.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

552

1.25

1.04

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

3622

0.91

1.03

2.3

2.2

g/l

10.2

10.3

0.07

268

2988

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

634

1.23

1.02

1.1

97.4

94.6

0.45

583

(4146454)

122

1037

1.18

1.01

2.8

2.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.88

1.00

2.0

2.2

—

(3022689) Creatine [Moles/volume] in Urine

238

0.63

1.00

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

426

0.73

0.99

2.6

33.9

35.6

—

157

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

807

0.80

0.99

1.6

1.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.80

0.98

1.3

ml/s/173m2

0.5

0.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

527

0.76

0.98

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

424

0.73

0.97

1.9

1.6

u/l

4.7

6.4

2.35

359

(3010144) Erythrocytes [#/volume] in Synovial fluid

871

0.81

0.97

1.5

1.3

e6/l

73673.1

171650.3

1.58

593

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

486

1.26

0.97

1.3

1.4

umol/l

15.2

14.1

0.36

459

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

275

1.35

0.96

1.3

1.4

24.1

22.9

0.09

228

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

1753

1.13

0.96

1.5

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

648

0.79

0.95

1.1

—

75.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.65

0.94

1.5

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

139

1601

0.87

0.93

1.6

1.7

iu/l

6.9

4.6

0.64

500

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

160

1400

1.15

0.93

1.3

1.4

—

(3011648) Oxygen content in Venous blood

642

1.22

0.93

1.4

2.1

11.0

10.8

0.20

642

(3036670) Protein [Mass/volume] in Synovial fluid

316

0.70

0.92

1.1

1.2

g/l

39.0

39.4

0.05

160

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

409

1.27

0.92

1.1

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.73

0.92

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

436

1.26

0.92

1.1

—

(3036603) Volume of Urine

553

1.23

0.91

1.6

1794.0

1883.0

0.23

147

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

296

3251

0.91

2.8

3.1

ratio

1.4

3.3

2.16

257

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

410

1.27

0.91

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

326

0.70

0.90

1.2

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

102

1.57

0.90

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

305

3342

0.91

0.90

2.8

3.1

mg/l

80.3

74.9

0.08

256

2705

(3028026) IgM [Mass/volume] in Serum or Plasma

411

4441

0.92

0.89

2.0

1.8

g/l

1.5

1.3

0.38

371

3971

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

718

0.81

0.88

1.9

1.7

mg/l

4.8

4.5

0.20

680

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.91

0.88

4.1

2.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

794

1.19

0.87

1.3

u/l

15.2

13.5

0.19

720

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1151

0.85

0.87

1.4

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

847

0.83

0.86

1.1

au/ml

11.9

12.5

—

(3023410) Appearance of Cerebral spinal fluid

649

0.80

0.86

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

306

3342

0.91

0.85

2.8

3.1

mg/l

40.2

49.9

1.09

256

2704

(40761535) Cells panel - Urine sediment

714

7551

0.94

0.85

3.5

3.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

333

0.72

0.85

1.3

—

(3044941) Cell count panel - Synovial fluid

116

1341

0.86

0.84

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

527

5628

0.93

0.84

2.6

2.7

g/l

10.3

10.6

0.76

476

5131

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

251

0.68

0.84

1.1

87.1

94.2

0.44

187

(40768800) Prostate Pathology biopsy report

205

2283

0.90

0.84

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

435

0.76

0.84

1.2

1.1

nmol/l

3.0

10.6

1.00

(3051101) Glucose [Moles/volume] in Cord blood

191

0.63

0.84

4.3

6.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

153

1349

1.14

0.83

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

142

1246

1.14

0.82

1.3

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1048

0.85

0.82

1.2

u/ml

284.8

291.3

0.07

645

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1134

0.85

0.82

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

667

0.81

0.82

1.3

titre

116.0

287.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

115

0.52

0.82

1.2

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

840

0.83

0.80

1.5

30.5

28.4

0.19

527

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

3859

0.92

0.80

2.3

2.2

g/l

3.8

0.38

243

2707

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

133

1514

0.88

0.79

1.2

1.3

u/l

36.8

40.9

0.18

114

1298

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

3867

0.92

0.79

2.3

2.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.3

—

(3020491) Glucose [Moles/volume] in Blood

586

0.80

0.79

1.6

2.1

mmol/l

7.8

7.0

0.77

396

(3037756) Immunofixation for Serum or Plasma

197

2188

0.90

0.79

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

761

0.83

0.78

1.7

1.6

u/ml

34.3

25.3

0.72

162

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.52

0.78

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.59

0.78

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

440

0.77

1.7

2.2

e9/l

0.2

0.93

389

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

359

3872

0.92

0.77

2.3

2.2

g/l

7.6

7.4

0.91

259

2815

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

923

8817

1.05

0.77

2.2

2.4

ug/l

5.2

7.1

3.23

777

7534

(44786800) Granulocytes/100 leukocytes in Body fluid

140

1.43

0.76

1.3

28.4

23.7

0.21

104

(3008116) Ketones [Moles/volume] in Urine by Test strip

157

1.40

0.76

1.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

245

0.69

0.76

1.6

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

438

4092

1.07

0.76

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

166

1.39

0.75

1.4

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.08

0.74

2.8

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

166

1485

1.12

0.74

1.3

1.5

nmol/l

0.9

0.8

0.49

139

1222

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

597

1.19

0.73

1.3

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.00

0.72

1.2

1.1

1.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

709

6739

1.06

0.72

1.5

1.7

1.6

0.15

604

5672

(3009445) Proteinase 3 Ab [Units/volume] in Serum

344

3703

0.93

0.72

1.4

1.5

u/ml

24.8

19.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

101

1161

0.87

0.72

1.8

1.7

mu/l

262.7

302.1

1.04

1071

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.58

0.71

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

489

1.21

0.71

2.2

2.1

ug/min

48.7

170.9

1.55

120

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

122

1074

1.14

0.71

1.3

nmol/l

0.6

2.7

0.83

114

1025

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

108

943

1.15

0.70

1.3

nmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

533

0.81

0.70

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.69

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

205

0.68

0.69

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

205

0.68

0.69

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

205

0.68

0.69

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

205

0.68

0.69

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

146

0.62

0.69

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

411

1.22

0.66

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

402

1.22

0.66

4.6

3.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

3593

0.93

0.65

2.4

2.3

g/l

3.2

3.1

0.56

250

2756

(40760888) Immunoglobulin light chains.free panel - Serum

231

2514

0.92

0.65

2.5

3.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

141

1263

1.12

0.64

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

360

0.78

0.64

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

281

0.75

0.63

1.3

1.2

g/l

—

0.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

405

1.21

0.62

1.3

1.2

—

(4211845)

442

1.20

0.62

4.4

3.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

279

0.75

0.61

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

226

1.28

0.61

5.2

8.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1048

0.88

0.60

2.1

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.60

0.0

3.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.60

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.60

0.0

1.1

—

2.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

791

0.86

0.60

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

1576

1.10

0.59

1.2

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

133

1195

1.11

0.59

1.9

2.2

mg/l

39.0

26.6

0.79

297

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.51

0.58

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

162

0.68

0.58

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3285

32296

1.03

0.58

2.2

nmol/l

76.2

79.1

6.76

2916

28194

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

336

1.22

0.58

1.9

2.5

—

(3003129) Base excess in Capillary blood by calculation

265

0.75

0.58

1.7

1.8

mmol/l

-0.2

0.6

0.55

244

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

295

3159

0.93

0.58

1.7

1.8

u/l

38.5

0.01

261

2691

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

121

1083

1.12

0.58

1.3

nmol/l

0.2

0.3

—

(3045142) Bone marrow Pathology biopsy report

116

1036

1.12

0.57

1.2

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

173

0.69

0.57

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

193

1.30

0.57

1.1

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

105

933

1.13

0.57

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

586

1.16

0.56

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

111

990

1.12

0.56

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

385

4082

0.94

0.56

3.1

3.2

pmol/l

4.3

4.4

1.46

339

3551

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

141

1.35

0.56

1.2

u/l

34.4

284.4

0.57

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.57

0.56

1.6

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2776

28276

0.97

0.56

4.2

4.0

mg/mmol

10.6

9.6

0.47

1820

17818

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

172

0.70

0.56

1.3

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

462

0.82

0.56

1.7

2.2

e6/l

564.4

494.0

0.43

389

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

263

0.76

0.55

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

182

1983

0.92

0.55

1.7

1.9

mg/l

11.5

12.1

0.40

167

1817

(3029075) Extractable nuclear Ab panel - Serum

183

0.71

0.55

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

720

0.86

0.55

1.1

u/ml

0.9

1.8

1.18

280

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

228

0.75

0.54

1.0

1.1

miu/ml

1585.8

1633.9

0.05

228

(3029396) Erythrocyte agglutination [Presence] in Blood

1.58

0.54

1.7

2.0

—

(4015189)

284

0.77

0.54

1.9

2.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

376

1.20

0.54

1.2

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

159

0.69

0.54

2.5

3.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1109

0.89

0.52

1.4

1.6

g/l

0.9

0.8

0.23

842

(3012516) Albumin [Mass/volume] in Urine

2625

26733

0.98

0.52

3.3

3.2

mg/l

300.1

391.5

0.62

1775

17007

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

812

0.87

0.52

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

223

1.26

0.52

1.9

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

511

0.84

0.51

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

500

0.84

0.51

1.9

2.3

e6/l

435.4

580.0

1.01

208

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

168

0.71

0.50

1.3

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

156

0.70

0.49

1.5

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

2672

27184

0.98

0.49

3.3

3.2

mmol/l

7.5

7.3

0.94

2183

22310

(3036481) Cortisol [Moles/volume] in Serum or Plasma

701

6744

1.04

0.49

2.3

2.2

nmol/l

399.4

378.4

1.85

650

6122

(3022621) pH of Urine by Test strip

576

5518

1.05

0.49

3.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.49

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

116

1281

0.90

0.49

1.2

1.3

iu/l

38.3

33.8

0.63

1086

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

100

1112

0.90

0.48

1.7

1.5

63.3

61.4

0.17

702

(4268621)

596

1.14

0.48

2.3

—

(4133840)

172

1.28

0.48

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

344

0.81

0.47

1.1

1.3

mmol/l

6.1

6.2

0.17

322

(3008401) Mugwort IgE Ab [Units/volume] in Serum

592

0.86

0.47

1.0

1.1

u/ml

1.7

1.0

0.34

240

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

177

0.73

0.47

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

229

2140

1.07

0.46

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

173

1.27

0.46

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

210

0.76

0.46

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

892

1.11

0.45

1.2

u/ml

2.5

4.3

2.64

380

(3045716) Anion gap in Serum or Plasma

430

1.16

0.45

2.9

2.2

mmol/l

9.5

9.1

0.33

336

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.60

0.45

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

119

0.67

0.45

1.5

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

265

0.79

0.45

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

134

1461

0.92

0.45

1.1

1.2

u/ml

4.6

5.3

0.09

112

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.40

0.44

5.4

8.7

umol/l

0.3

0.08

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.45

0.44

1.5

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

275

1.20

0.43

2.0

1.9

—

(40758358) Immune stain study

1.61

0.43

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

182

1950

0.93

0.41

1.6

1.7

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.41

0.0

1.2

—

170.3

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.41

0.0

7.5

—

71.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

921

0.90

0.41

1.1

—

(4062490)

710

0.89

0.40

1.2

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

492

1.14

0.40

1.3

1.2

mmol/l

10.9

11.7

0.34

155

(3020630) Protein [Mass/volume] in Serum or Plasma

793

8177

0.97

0.40

2.5

g/l

65.1

66.1

2.80

707

7283

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

100

911

1.10

0.39

1.2

u/ml

4.5

4.3

0.04

289

(3026470) Cobalt [Mass/volume] in Blood

645

0.88

0.39

1.8

1.9

ug/l

3.8

3.7

0.04

566

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.31

0.39

3.3

4.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

153

1646

0.93

0.39

1.6

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.39

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.1

—

(40757373) Influenza virus identified in Isolate

193

0.78

0.39

1.3

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3747

37888

0.98

0.38

2.3

2.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

296

2813

1.05

0.38

1.1

titre

158.8

186.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

312

0.83

0.37

2.7

2.1

umol/l

53.8

57.8

0.36

242

(3025577) Chromium [Mass/volume] in Blood

631

0.89

0.37

1.9

2.0

ug/l

2.0

2.3

0.45

520

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

107

1.31

0.37

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

115

1247

0.92

0.37

1.3

u/l

17.6

10.6

2.94

997

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

116

0.69

0.36

1.4

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

429

0.86

0.36

1.5

1.9

3.7

—

101

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

180

0.78

0.36

1.4

1.5

ng/l

152.5

131.0

0.14

180

(3003888) Timothy IgE Ab [Units/volume] in Serum

609

0.89

0.36

1.0

1.1

u/ml

7.1

3.8

0.44

275

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.27

0.36

1.2

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.62

0.35

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

208

1.20

0.35

1.0

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

124

0.73

0.35

1.1

1.4

—

11.8

—

(3004775) Volume in Urine collected for unspecified duration

775

1.10

0.34

2.0

2.2

722.1

637.3

0.72

500

(3023419) Bacteria identified in Sputum by Culture

110

1190

0.92

0.34

2.9

2.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

155

0.77

0.33

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.30

0.33

1.2

1.3

pmol/l

17.1

21.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

155

1.23

0.32

1.1

1.8

ug/l

2.5

2.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.33

0.32

2.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

295

0.85

0.31

1.2

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1036

10588

0.98

0.31

4.3

4.8

32.8

33.1

0.33

666

6942

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

219

0.82

0.31

2.1

2.6

—

(3016750) Collection duration of Urine

532

1.11

0.31

2.2

2.1

min

495.4

496.5

0.03

381

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

120

1119

1.07

0.30

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.31

0.30

9.7

11.4

—

(40758292) HTLV I+II Ab panel - Serum

102

1.27

0.30

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

515

1.11

0.29

1.1

1.2

u/l

195.9

94.5

0.72

440

(3042010) Triglyceride [Moles/volume] in Pleural fluid

157

1.21

0.29

1.2

mmol/l

1.9

1.5

0.14

101

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

130

0.77

0.29

12.5

12.2

mmol/l

6.8

5.2

—

130

(3000060) B lymphocytes [#/volume] in Blood

139

1.22

0.29

1.2

1.9

e6/l

2300.0

1117.6

—

(44806118)

101

939

1.08

0.28

1.2

1.4

—

(44790047)

101

939

1.08

0.28

1.2

1.4

—

(44790049)

101

939

1.08

0.28

1.2

1.4

—

(44790048)

101

939

1.08

0.28

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

712

7293

0.97

0.27

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

168

1.19

0.27

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

557

1.10

0.26

1.1

1.2

—

(3014891) Appearance of Pleural fluid

159

1.20

0.26

1.9

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

137

1451

0.94

0.26

1.3

—

(3042631) Mycobacterium sp identified in Specimen

149

1410

1.06

0.26

2.1

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

708

0.92

0.26

1.2

1.4

g/l

0.4

0.07

502

(3028192) IgG subclass 2 [Mass/volume] in Serum

708

0.92

0.26

1.2

1.4

g/l

2.7

2.9

0.36

503

(3027135) IgG subclass 1 [Mass/volume] in Serum

708

0.92

0.26

1.2

1.4

g/l

6.8

7.0

0.14

499

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.26

0.26

1.9

1.7

umol/l

49.7

43.7

0.30

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.70

0.26

1.0

1.1

u/l

8.2

10.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.69

0.26

1.0

1.3

—

(44806071)

0.67

0.25

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.67

0.25

1.2

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.23

0.25

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

123

1.22

0.25

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

502

1.10

0.25

1.1

1.2

u/l

43.8

25.6

0.73

419

(3003338) MCHC [Mass/volume]

6116

60864

1.01

0.24

39.8

22.0

g/l

329.2

331.7

76.33

6066

60252

(3036048) Francisella tularensis Ab [Titer] in Serum

159

0.82

0.24

1.0

1.2

—

484.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

840

1.07

0.24

1.1

111.0

114.8

0.61

733

(3005011) Chlamydia sp Ab [Titer] in Serum

1.18

0.24

1.7

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

104

1107

0.94

0.24

1.3

1.4

u/ml

101.1

124.1

1.47

243

(3014599) Egg white IgE Ab [Units/volume] in Serum

191

0.84

0.24

1.1

1.0

u/ml

1.2

0.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

126

0.79

0.24

1.1

—

(3044927) Protein electrophoresis panel - Urine

111

1045

1.06

0.24

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

1270

1.06

0.23

1.2

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

591

1.08

0.23

1.7

2.1

33.0

40.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

190

1.16

0.23

5.0

8.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

708

1.07

0.22

1.2

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.25

0.22

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

354

3435

1.03

0.22

2.2

2.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.22

0.22

1.4

1.2

nmol/l

23.4

28.0

—

(3000285) Sodium [Moles/volume] in Blood

135

0.81

0.22

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.19

0.21

1.6

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

513

0.92

0.21

3.6

3.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3479

35044

0.99

0.21

4.9

5.4

ug/l

3.2

3.9

1.18

3017

31060

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

440

0.91

0.21

1.3

u/ml

0.2

1.5

2.59

231

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

101

0.79

0.21

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

450

0.91

0.21

1.4

nmol/l

0.3

0.2

0.37

327

(40757494) Bilirubin.total [Moles/volume] in Blood

498

1.08

0.21

2.6

2.1

umol/l

22.0

34.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

1.20

0.20

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

219

0.87

0.20

1.1

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

1761.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.25

0.20

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

208

0.87

0.20

2.0

2.6

—

(3046861) Legionella sp Ag [Presence] in Urine

1.22

0.20

1.3

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

100

1056

0.95

0.20

1.1

1.4

—

(3017704) Immunofixation for Urine

562

0.92

0.19

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

218

2104

1.04

0.19

3.0

2.7

mg/l

1.8

1.7

1.29

196

1878

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

212

1.13

0.19

2.2

2.3

mmol/l

8.2

7.8

0.15

136

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

218

0.87

0.19

1.2

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

165

0.85

0.19

1.5

1.9

mmol/l

1.2

0.31

160

(3044009) aPTT.lupus sensitive (LA screen)

1.13

0.18

1.0

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

301

0.90

0.18

1.7

1.9

umol/l

120.8

121.3

0.00

165

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

109

1.19

0.18

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

580

0.93

0.18

1.1

1.2

titre

84.3

138.0

—

103

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

227

0.88

0.18

1.3

1.9

32.9

30.0

0.28

208

(3003740) Influenza virus B Ag [Presence] in Specimen

619

1.07

0.18

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

703

0.94

0.18

1.2

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

493

1.08

0.17

2.3

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

174

0.86

0.17

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1010

0.95

0.17

1.1

iu/ml

8741.4

1045.9

0.41

203

(3027923) C peptide [Moles/volume] in Serum or Plasma

435

1.08

0.17

1.2

1.3

nmol/l

1.2

0.15

329

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.21

0.17

6.6

5.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

161

1672

0.96

0.17

1.2

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.13

0.17

1.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

278

2858

0.97

0.17

1.6

titre

146.0

285.8

—

133

(3025315) Body weight

0.72

0.16

6.8

5.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

288

0.90

0.16

2.5

2.8

umol/l

30.8

28.6

0.58

215

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

177

1.13

0.16

1.4

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

272

2649

1.03

0.16

1.1

u/ml

2.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

312

1.09

0.15

2.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.78

0.15

1.0

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

149

1.14

0.15

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

452

0.93

0.15

1.0

u/ml

5.7

2.4

0.52

173

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

293

1.09

0.15

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

1113

1.04

0.15

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

111

1064

1.04

0.15

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.14

0.15

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

523

0.94

0.15

1.1

1.0

u/ml

2.2

1.7

—

123

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

564

0.94

0.15

6.1

5.0

u/ml

37.7

73.2

1.02

162

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

192

0.89

0.14

1.2

1.1

—

(44806420)

323

1.08

0.14

2.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

223

0.90

0.14

1.4

—

1605879.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

202

0.89

0.14

1.1

u/ml

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

786

7756

1.01

0.14

1.4

1.6

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

0.82

0.13

1.1

1.5

mu/l

4197.8

399.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

0.82

0.13

1.1

1.5

72.8

72.2

—

(3014051) Protein [Presence] in Urine by Test strip

195

1896

1.03

0.13

2.5

2.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

0.80

0.13

1.9

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

128

0.86

0.13

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

284

0.92

0.13

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

356

0.93

0.13

1.1

1.0

u/ml

1.6

0.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

106

0.85

0.13

3.8

2.6

—

81.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

376

0.93

0.13

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

190

0.89

0.13

1.5

1.6

ug/l

10.3

9.5

0.39

190

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

384

1.07

0.12

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

805

1.04

0.12

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

171

1.11

0.12

1.0

1.3

94.3

82.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

303

0.92

0.12

1.8

1.9

ug/l

69.5

55.6

0.88

292

(3011412) CD3 cells [#/volume] in Blood

702

0.95

0.12

1.9

2.1

e9/l

1.2

1.1

0.18

433

(3034426) Prothrombin time (PT)

210

1.10

0.12

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

424

1.06

0.12

7.3

6.1

—

(4024509)

867

1.04

0.11

1.7

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

157

0.89

0.11

1.1

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

956

1.04

0.11

3.9

3.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

105

1.14

0.11

2.0

2.1

—

(3008295) Osmolality of Serum or Plasma

892

0.96

0.10

1.2

1.3

mosm/kgh2o

275.1

277.9

0.54

670

(3011985) Renin [Units/volume] in Plasma

100

1034

0.97

0.10

1.3

1.4

mu/l

62.8

58.8

0.07

914

(3050129) First trimester maternal screen panel - Serum or Plasma

239

0.92

0.10

1.3

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

202

1.09

0.10

1.0

1.1

—

(40768793) Breast Pathology biopsy report

142

1457

0.97

0.10

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

197

0.91

0.09

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

106

1.13

0.09

2.1

2.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.06

0.09

1.2

—

(21494434) Karyotype in Bone marrow

828

0.97

0.09

1.1

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

116

1.12

0.09

1.1

u/ml

0.9

0.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

228

2321

0.98

0.09

2.4

2.3

ug/min

138.7

111.3

0.31

124

1348

(3008536) Aspergillus sp Ab [Presence] in Serum

165

1.09

0.08

1.4

1.8

—

(3019174) dRVVT (LA screen)

1.05

0.08

1.0

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.05

0.08

2.5

3.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

400

1.05

0.08

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

107

1.12

0.08

2.0

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

129

1259

1.02

0.08

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.78

0.08

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.08

3.3

4.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.08

0.08

1.4

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.08

0.08

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

342

1.05

0.08

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

313

1.05

0.07

1.6

1.5

umol/l

11.7

13.1

0.10

218

(3015183) Erythrocyte sedimentation rate

215

1.07

0.07

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

137

1.09

0.07

2.1

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.04

0.07

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.84

0.07

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.83

0.07

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.83

0.07

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.83

0.07

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

428

0.96

0.07

1.4

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

0.82

0.07

1.0

1.2

—

55.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

122

0.90

0.07

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

206

1.07

0.07

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

206

1.07

0.07

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

620

1.03

0.07

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

356

0.95

0.06

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

207

1.06

0.06

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

207

1.06

0.06

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

162

0.93

0.06

1.5

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

119

1.09

0.06

3.1

1.3

109.7

107.9

0.06

113

(3033923) Metanephrine [Moles/time] in 24 hour Urine

172

0.93

0.06

1.2

umol/24h

0.7

—

(4198724)

131

0.92

0.05

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

491

4872

1.01

0.05

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

188

1.06

0.05

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.05

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

515

1.03

0.05

1.8

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1900

18942

1.00

0.05

3.6

4.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

107

1052

1.02

0.04

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

146

1479

0.99

0.04

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

170

1.06

0.04

1.0

1.2

91.6

82.7

—

(3035933) Granulocytes/100 leukocytes in Blood

129

0.93

0.03

1.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

210

1.05

0.03

1.2

1.3

nmol/l

95.5

143.7

1.82

152

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

321

0.97

0.03

1.5

1.7

nmol/l

6.0

5.9

0.01

273

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

220

0.95

0.03

1.6

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

131

1.07

0.03

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

488

1.02

0.03

1.4

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

187

1888

0.99

0.03

3.7

3.8

mg/l

32.6

29.4

0.50

117

1235

(3004616) Nuclear Ab [Presence] in Serum

914

0.98

0.03

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

125

1265

0.99

0.03

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

171

1.05

0.03

1.3

1.4

—

(3048879) Bone marrow aspiration report

300

0.97

0.03

1.4

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

199

0.95

0.03

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

531

0.98

0.03

1.7

2.0

14.4

16.0

0.25

205

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

221

1.04

0.03

1.3

29.9

34.3

0.24

143

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

251

1.04

0.02

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

259

0.97

0.02

1.4

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

420

1.02

0.02

1.0

1.1

u/ml

5.0

2.5

0.60

160

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

711

0.98

0.02

1.3

1.2

nmol/l

1.3

1.5

0.78

630

(3047352) Trisomy 18 risk [Likelihood] in Fetus

172

1.05

0.02

1.4

—

(4306422)

869

1.01

0.02

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

258

0.97

0.02

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

268

0.97

0.02

4.8

5.4

65.5

71.5

0.51

209

(3051593) INR in Capillary blood by Coagulation assay

539

0.98

0.02

12.5

11.3

—

(3028433) Virus identified in Specimen by Culture

278

0.97

0.02

1.2

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

235

2362

0.99

0.01

1.4

iu/ml

15.0

18.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

368

0.98

0.01

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

137

0.95

0.01

1.2

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

683

6845

1.00

0.01

3.5

3.8

ng/l

98.6

96.8

0.18

588

5736

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

422

1.02

0.01

2.2

2.8

u/l

224.2

208.8

0.26

417

(3000093) Morphology [Interpretation] in Blood Narrative

919

0.99

0.01

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

881

1.01

0.01

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

187

0.96

0.01

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

528

0.98

0.01

1.1

1.3

promille

1.1

1.2

0.27

406

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

493

1.01

0.01

1.4

u/l

42.1

32.8

0.84

401

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

154

0.97

0.00

4.5

7.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

107

1.03

0.00

1.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

235

0.98

0.00

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

582

1.00

0.00

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

145

0.97

0.00

1.1

umol/l

17.8

16.4

1.04

130

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

962

1.00

0.00

1.2

1.3

pmol/l

265.6

297.0

0.34

730

(4212803)

101

0.99

0.00

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.01

0.00

7.1

5.2

ug/min

55.6

47.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

0.98

0.00

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

207

1.01

0.00

1.2

mmol/l

1.4

1.6

0.27

129

(3043238) Trisomy 21 risk [Likelihood] in Fetus

179

1.01

0.00

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

168

1.01

0.00

1.0

1.3

mg/l

1.2

58.2

0.79

129

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.90

0.00

1.4

1.2

umol/24h

1.6

1.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.94

0.00

1.2

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.2

—

11.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.93

0.00

1.0

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.02

0.00

1.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.89

0.00

1.3

—

555.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

140.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.89

0.00

2.0

1.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.91

0.00

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_COLORECTAL – Colorectal cancer

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Colorectal cancer

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints